General
Preferred name
Metrizamide
Synonyms
Amipaque ()
Telebrix 300 ()
WIN-39103 ()
WIN 39103 ()
Metrizamida ()
P&D ID
PD009471
CAS
31112-62-6
Tags
available
drug
Approved by
FDA
First approval
1978
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Metrizamide (Amipaque) is used as the contrast medium for angiography in neuroradiological investigations[1]. Metrizamide inhibits human brain hexokinase[2].
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
7
ChEMBL Approved Drugs
ChEMBL Drugs
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
Prestwick Chemical Library
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
24
Molecular Weight
788.85
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
6
Rotatable Bonds
5
Ring Count
2
Aromatic Ring Count
1
cLogP
-0.03
TPSA
168.66
Fraction CSP3
0.5
Chiral centers
5.0
Largest ring
6.0
QED
0.23
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Hexokinase
Pathway
Metabolic Enzyme/Protease
Source data
